We take our role in your health very seriously. Come in today to see how we can help.
Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
An exclusive HealthDay Interview with Alicia Zhou, PhD, CEO of the Cancer Research Institute.
A new study finds just 18% of former and current smokers who are eligible for lung cancer CT scans are getting the tests.